AMBERA DEDIC: Open Payments
NPI 1003498213 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,121 in 20 payments from 10 companies in 2025. Trend: 2023 $607 · 2024 $918 · 2025 $2,121
Food & beverage: $2,121
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $490 |
| Mannkind Corporation | 5 | $320 |
| Novo Nordisk Inc | 2 | $233 |
| Radius Health, Inc. | 2 | $219 |
| Abbott Laboratories | 1 | $176 |
| Dexcom, Inc. | 1 | $153 |
| Insulet Corporation | 1 | $149 |
| Sequel Med Tech, LLC | 1 | $145 |
| BETA BIONICS, INC. | 1 | $121 |
| Lilly USA, LLC | 1 | $115 |
Products named: MINIMED 780G, AFREZZA, Tymlos, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, OMNIPOD, TWIIST, Wegovy.
Industry payments across CA — which companies pay providers there.
